Category Archives: Neuroscience

Brain-Computer Interface Translates Brain Signals Associated with Handwriting into Text | Computer Science, Neuroscience – Sci-News.com

Researchers with the BrainGate Collaboration have deciphered the brain activity associated with handwriting: working with a 65-year-old (at the time of the study) participant with paralysis who has sensors implanted in his brain, they used an algorithm to identify letters as he attempted to write them; then, the system displayed the text on a screen; by attempting handwriting, the participant typed 90 characters per minute more than double the previous record for typing with a brain-computer interface.

As part of the BrainGate clinical trial, researchers are using tiny electrode arrays to record signals from the motor cortex of the brain; those signals can then be used to control robotic prostheses, computers or other devices; the hope is that such a system may one help restore communication and movement in people with paralysis due to injury or illness. Image credit: BrainGate.org.

Brain-computer interfaces can restore communication to people who have lost the ability to move or speak.

So far, a major focus of brain-computer interface research has been on restoring gross motor skills, such as reaching and grasping or point-and-click typing with a computer cursor.

However, rapid sequences of highly dexterous behaviors, such as handwriting or touch typing, might enable faster rates of communication.

Scientists from the BrainGate Collaboration have been working for several years on such systems.

Previous studies have involved trial participants thinking about the motions involved in pointing to and clicking letters on a virtual keyboard. That system enabled one participant to type 40 characters per minute, which was the previous record speed.

For the latest study, the BrainGate researchers wanted to find out if asking a participant to think about motions involved in writing letters and words by hand would be faster.

An important mission of our BrainGate Consortium research is to restore rapid, intuitive communication for people with severe speech or motor impairments, said Professor Leigh Hochberg, a critical care neurologist in the School of Engineering and Carney Institute for Brain Science at Brown University, the Center for Neurotechnology and Neurorecovery at Massachusetts General Hospital, and the Department of Veterans Affairs Providence Healthcare System.

The new demonstration of fast, accurate neural decoding of handwriting marks an exciting new chapter in the development of clinically useful neurotechnologies.

We want to find new ways of letting people communicate faster, said Dr. Frank Willett, a neuroscientist at Stanford University and the Howard Hughes Medical Institute.

This new system uses both the rich neural activity recorded by intracortical electrodes and the power of language models that, when applied to the neurally decoded letters, can create rapid and accurate text.

As part of the clinical trial, the scientists placed two tiny electrodes about the size of a baby aspirin in a part of the trial participants brain associated with the movement of his right arm and hand.

Using signals the sensors picked up from individual neurons when the man imagined writing, a machine learning algorithm recognized the patterns his brain produced with each letter.

With this system, the man could copy sentences and answer questions at a rate similar to that of someone the same age typing on a smartphone.

The system is so fast because each letter elicits a highly distinctive activity pattern, making it relatively easy for the algorithm to distinguish one from another, Dr. Willett said.

The innovation could, with further development, let people with paralysis rapidly type without using their hands, said Dr. Krishna Shenoy, a researcher at Stanford University.

This technology and others like it have the potential to help people with all sorts of disabilities, added Dr. Jose Carmena, a neural engineer at the University of California, Berkeley.

Though the findings are preliminary, its a big advancement in the field.

Brain-computer interfaces convert thought into action. This paper is a perfect example: the interface decodes the thought of writing and produces the action.

The people who enroll in the BrainGate trial are amazing, Professor Hochberg said.

Its their pioneering spirit that not only allows us to gain new insights into human brain function, but that leads to the creation of systems that will help other people with paralysis.

The teams work was published in the journal Nature.

_____

F.R. Willett et al. 2021. High-performance brain-to-text communication via handwriting. Nature 593, 249-254; doi: 10.1038/s41586-021-03506-2

See the article here:
Brain-Computer Interface Translates Brain Signals Associated with Handwriting into Text | Computer Science, Neuroscience - Sci-News.com

Global Neuroscience Market To build up Huge Returns Over Estimated Timeframe Over 2020-2026 ZMR Study The Courier – The Courier

The business report released by Zion Market Research onGlobal Neuroscience Market To build up Huge Returns Over Estimated Timeframe Over 2020-2026 ZMR Studyis focused to facilitate a deep understanding of the market definition, potential, and scope. The report is curate after deep research and analysis by experts. It consists of an organized and methodical explanation of current market trends to assist the users to entail in-depth market analysis. The report encompasses a comprehensive assessment of different strategies like mergers & acquisitions, product developments, and research & developments adopted by prominent market leaders to stay at the forefront in the global market.

FREE | Request Sample is Available @https://www.zionmarketresearch.com/sample/neuroscience-market

The major players in the globalNeuroscience MarketareAlpha Omega, Axion Biosystems, Blackrock Microsystems LLC, Femtonics Ltd., Intan Technologies, LaVision Biotec GmbH, Mediso Medical Imaging Systems, Neuralynx Inc., NeuroNexus Technologies, Neurotar Ltd., Newport Corporation, Plexon Inc., Scientifica Ltd., Sutter Instrument Corporation, Thomas Recording GmbH, and Trifoil Imaging Inc.

Along with contributing significant value to the users, the report by Zion Market Research has focused on Porters Five Forces analysis to put forward the wide scope of the market in terms of opportunities, threats, and challenges. The information extracted through different business models like SWOT and PESTEL is represented in the form of pie charts, diagrams, and other pictorial representations for a better and faster understanding of facts. The report can be divided into following main parts.

Growth drivers:

The report provides an accurate and professional study of global Neuroscience Market business scenarios. The complex analysis of opportunities, growth drivers, and the future forecast is presented in simple and easily understandable formats. The report comprehends the Neuroscience Market by elaborating the technology dynamics, financial position, growth strategy, product portfolio during the forecast period.

Download Free PDF Report Brochure @https://www.zionmarketresearch.com/requestbrochure/neuroscience-market

Segmentation:

The report is curate on the basis of segmentation and sub-segmentation that are aggregated from primary and secondary research. Segmentation and sub-segmentation is a consolidation of industry segment, type segment, channel segment, and many more. Further, the report is expanded to provide you thorough insights on each segment.

Regional analysis:

The report covers all the regions in the world showing regional developmental status, the market volume, size, and value. It facilitates users valuable regional insights that will provide a complete competitive landscape of the regional market. Further, different regional markets along with their size and value are illustrated thoroughly in the report for precise insights.

Inquire more about this report @https://www.zionmarketresearch.com/inquiry/neuroscience-market

Competitive analysis:

The report is curate after a SWOT analysis of major market leaders. It contains detailed and strategic inputs from global leaders to help users understand the strength and weaknesses of the key leaders. Expert analysts in the field are following players who are profiled as prominent leaders in the Neuroscience Market. The report also contains the competitive strategy adopted by these market leaders to the market value. Their research and development process was explained well enough by experts in the global Neuroscience Market to help users understand their working process.

Key Details of the Existing Report Study:

Frequently Asked Questions

Thanks for reading this article;you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the clients needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to usafter allif you do well, a little of the light shines on us.

Contact Us:

Zion Market Research244 Fifth Avenue, Suite N202New York, 10001, United StatesTel: +49-322 210 92714USA/Canada Toll-Free No.1-855-465-4651Email:sales@zionmarketresearch.comWebsite:https://www.zionmarketresearch.com

Follow this link:
Global Neuroscience Market To build up Huge Returns Over Estimated Timeframe Over 2020-2026 ZMR Study The Courier - The Courier

Neuroscience market size to expand momentously over 2020-2025 – Fractovia News

Market Study Report has released a new research study on Neuroscience market Analysis 2020-2025 inclusive of one or more factors covering regional opportunities, application landscape, product demand trends, and end-use portfolio of the industry over the forecast timeframe. The report also outlines the competitive framework of the Neuroscience industry detailing the SWOT analysis and market share dominance of the prominent players.

.

Request a sample Report of Neuroscience Market at:https://www.marketstudyreport.com/request-a-sample/2903546?utm_source=fractovia.org&utm_medium=SK

The new research report on Neuroscience market offers a thorough analysis of this industry vertical. As per the report, Neuroscience market is predicted to acquire notable gains and record a significant growth during the estimated timeframe.

The Neuroscience market report emphasizes on the current industry trends and entails details about market size, revenue forecast, and sales volume over the study duration. In addition, the report provides data with regards to the market drivers that will positively influence the revenue graph, alongside the segmentations influencing the industry size.

The major takeaways from the Neuroscience market report with regards to the regional contribution:

Ask for Discount on Neuroscience Market Report at:https://www.marketstudyreport.com/check-for-discount/2903546?utm_source=fractovia.org&utm_medium=SK

Other fundamentals of the Neuroscience market report are mentioned below:

The content of the study subjects, includes a total of 15 chapters:

The research study can answer the following Key questions:

For More Details On this Report: https://www.marketstudyreport.com/reports/global-neuroscience-market-2020-by-company-regions-type-and-application-forecast-to-2025

Related Reports:

1. Global Tendinitis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025Read More: https://www.marketstudyreport.com/reports/global-tendinitis-treatment-market-2020-by-company-regions-type-and-application-forecast-to-2025

2. Global Sterilization Technology Market 2020 by Company, Regions, Type and Application, Forecast to 2025Read More: https://www.marketstudyreport.com/reports/global-sterilization-technology-market-2020-by-company-regions-type-and-application-forecast-to-2025

Related Report : https://www.marketwatch.com/press-release/global-iot-in-construction-market-growth-share-demand-and-analysis-forecasts-by-2027-2021-05-20

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

Originally posted here:
Neuroscience market size to expand momentously over 2020-2025 - Fractovia News

LCMC Health Neuroscience Institute created at WJMC New Orleans CityBusiness – New Orleans CityBusiness

LCMC Health has established a Neuroscience Institute at West Jefferson Medical Center.

A news release describes the Institute as the first of its kind in the Gulf South, with a team of physicians, researchers and educators collaborating to help people suffering from conditions such asParkinsons, stroke, brain tumor, or back and spine conditions.

The Institute is partnering with the Culicchia Neurological Clinic, which has been part of West Jefferson for 60 years specializing in a wide array of disorders affecting the nervous system and spine. The two entities will share a newly designed, state-of-the-art facility on the 6th and 7th floors of the South Tower of WJMC. A staircase and elevator will connect the floors for ease of access for patients who will also benefit from an expanded waiting room and modern finishes creating a more comfortable experience for patients and their families, the release said.

Multiple specialties will be available to patients at one location, such as neurology, neurosurgery, neurointerventional radiology, neurorehabilitation, neuro-oncology, neuro-otology, neurocritical care, stroke care, spine care and more.

The hospital on the West Bank has had other additions over the past several months as part of $90 million in renovations and expansion projects,including the completion of a new Outpatient Surgery Center, physician clinics entry, endoscopy department, emergency department and a new main hospital entrance.

Read the original here:
LCMC Health Neuroscience Institute created at WJMC New Orleans CityBusiness - New Orleans CityBusiness

Thesis by Krotinger ’19 Published in PLOUS ONE – Wesleyan Connection

Anna Krotinger 19 wrote an undergraduate thesis examining a dance intervention for Parkinsons disease (PD) and underlying cognitive mechanisms relating to rhythm that was published on May 6 at the scientific journal PLOS ONE.

Krotingers thesis, titled Rhythm and groove as cognitive mechanisms of dance intervention in Parkinsons disease, builds off her studies in neuroscience and behavior, in which she majored at Wesleyan.

Music and dance encourage spontaneous rhythmic coupling between sensory and motor systems; this has inspired the development of dance programs for PD, the abstract reads. Here we assessed the therapeutic outcome and some underlying cognitive mechanisms of dance classes for PD, as measured by neuropsychological assessments of disease severity as well as quantitative assessments of rhythmic ability and sensorimotor experience.

Tags:alumni publications Class of 2019 Neuroscience

Read more here:
Thesis by Krotinger '19 Published in PLOUS ONE - Wesleyan Connection

The Neuroscience Market To Witness A Spike Amidst Entry Of New Players The Courier – The Courier

The Neuroscience Market report tabled by Persistence Market Research focuses on the parameters of the 4th industrial revolution, which includes technology-driven healthcare solutions, with several breakthroughs in this regard. The entire supply chain right from diagnostics to the delivery of medicines, is being driven by the technological advancements in healthcare.

With healthy CAGR of 6.4%, theglobalneuroscience marketis likely to grow from US$ 301.6 Mn in 2016 to US$ 520.8 Mn by 2025 end. This growth is mainly fuelled by advancement in neuroimaging and increasing R & D in neuroinformatics. Neuroscience Market: Global Industry Analysis (2012-2016)and Forecast (2017-2025),is the new publication of Persistence Market Research that focuses on merger and acquisition, strategic collaborations and technology, and technology transfer agreements, which play a vital role in the global neuroscience market.

Get Sample Copy of Report @https://www.persistencemarketresearch.com/samples/13390

Company Profiles

North America and Europe are expected to dominate the global neuroscience market in the assessed period of 8-years that is between 2017 and 2025.

Global Neuroscience Market: Relevance and Impact of Factors

Get To Know Methodology of Report @https://www.persistencemarketresearch.com/methodology/13390

Global Neuroscience Market: Forecast by Component Type

On the basis of component type, the global neuroscience market is segmented into instrument, software and services. Instrument segmented is sub-segmented into MRI imaging systems and neuromicroscopy, while services segmented divided into consulting services, installation services and maintenance services.

Instrument segment dominated the global neuroscience market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. Instrument segment is the most attractive segment, with attractiveness index of 2.6 over the forecast period.

Instrument segment was valued atUS$ 221.6 Mnin 2016 and is projected to be valued atUS$ 408.1 Mn in 2025growing at aCAGR of 7.2%during the forecast period. This segment is expected to accounts for high revenue contribution to the global neuroscience market as compared to software and services segments over the forecast period.

Software segment is expected to be the second most lucrative segment in the global neuroscience market, with attractiveness index of0.3 duringthe forecast period. This segment was accounted for 15.4% value share in 2017 which is expected to drop down to 12.9 % revenue share in 2025.

Global Neuroscience Market: Forecast by End User

On the basis of end user, global neuroscience market is segmented into hospitals, diagnostic laboratories, research institutes, and academic institutes.

Diagnostics laboratory segment is expected to be the second most lucrative segment in the global neuroscience market by 2025 end. However, in terms of CAGR and revenue share, hospitals segment is expected to lead he market throughout the estimated period. In 2025, hospital segment is likely to grab 40.2% market share in 2025, expanding at a robustCAGR of 7.3%during the estimated period.

Research institutes segment is expected to be the least attractive segment in the global neuroscience market, with attractiveness index of 0.7 during the forecast period.

Access Full Report @https://www.persistencemarketresearch.com/checkout/13390

Global Neuroscience Market: Forecast by Region

On the basis of region, global neuroscience market is segmented into North America, Latin America, Europe, APAC and MEA. North America dominated the global neuroscience market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period.

North America is projected to be the most attractive market with attractiveness index of 2.3 during the forecast period. Europe is expected to be the second most lucrative market, with attractiveness index of 1.1 respectively during the forecast period.

Europe Neuroscience market accounted for 23.9% share in 2017 and is projected to account for 23.1% share by 2025 end.

Explore Extensive Coverage of Persistence Market Researchs Healthcare Industry

About us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

Contact us:

Persistence Market ResearchAddress 305 Broadway, 7th Floor, New York City, NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales sales@persistencemarketresearch.com

The rest is here:
The Neuroscience Market To Witness A Spike Amidst Entry Of New Players The Courier - The Courier

Cognitive problems caused by repetitive and mild blows to the head could be treated, study suggests – News-Medical.Net

A neurologic pathway by which non-damaging but high frequency brain impact blunts normal brain function and causes long-term problems with learning and memory has been identified. The finding suggests that tailored drug therapy can be designed and developed to reactivate and normalize cognitive function, say neuroscientists at Georgetown University Medical Center.

The investigators, working with collaborators at the National Institutes of Health, had previously found that infrequent mild head impacts did not have an effect on learning and memory, but in their new study, reported May 10 in Nature Communications (DOI: 10.1038/s41467-021-22744-6), the investigators found that when the frequency of these non-damaging head impacts are increased, the brain adapts and changes how it functions. The investigators have found the molecular pathway responsible for this down-tuning of the brain that can prevent this adaptation from occurring.

This study is the first to offer a detailed molecular analysis of what happens in the brain after highly repetitive and very mild blows to the head, using mice as an animal model, says the study's senior investigator, Mark Burns, PhD, an associate professor in Georgetown's Department of Neuroscience and head of the Laboratory for Brain Injury and Dementia.

"Most research in this area has been in mouse models with more severe brain injury, or in human brains with chronic traumatic encephalopathy (CTE)," he says. CTE is a degenerative brain disease found in people with a history of repetitive head impact. "This means that we have been focusing only on how CTE pathology develops. Our goal was to understand how the brain changes in response to the low-level head impacts that many young football players, for example, are regularly experiencing."

Researchers have found that the average high school and college football player receives 21 head impacts per week, while some specialized players, such as defensive ends, experience twice as many. Behavioral issues believed to come from head impact have been reported in athletes with exposure to repeated head impacts. Issues range from mild learning and memory deficits to behavioral changes that include aggression, impulsivity and sleep disorders.

These findings represent a message of hope to athletes and their families who worry that a change in behavior and memory means that CTE is in their future."

Mark Burns, PhD, Study's Senior Investigator

In this study with mice, researchers mimicked the mild head impacts experienced by football players. The mice showed slower learning and impaired memory recall at timepoints long after the head impacts had stopped. After the experiment, a detailed analysis of their brains showed that there was no inflammation or tau pathology, as is usually seen in the brains of brain trauma or people with CTE.

To understand the physiology underlying these memory changes, the study's co-first author, Bevan Main, PhD, assistant professor of neuroscience at Georgetown, conducted RNA sequencing of the brain. "There are many things that this type of analysis can point you to, such as issues with energy usage or CTE-like pathways being activated in nerve cells, and so on," Main says. "All of our sequencing studies kept pointing to the same thing - the synapses that provide communication between neurons."

The next step was to figure out how synaptic function was altered. Stephanie Sloley, PhD, a graduate of Georgetown's Interdisciplinary Program for Neuroscience and the study's other first co-author, conducted electrophysiology studies of different neurons charged with releasing varied neurotransmitters - chemicals passed between neurons, via synapses, that carry functional instructions. "The brain is wired via synaptic communication pathways, and while we found that these wires were intact, the way that they communicated using glutamate was blunted, repressed," says Sloley.

Glutamate is the most abundant neurotransmitter in the brain, and is found in more than 60% of brain synapses. It plays a role in synaptic plasticity, which is the way the brain strengthens or weaken signals between neurons over time to shape learning and memory.

"Glutamate is usually very tightly regulated in the brain, but we know that head impacts cause a burst of glutamate to be released. We believe that brain is adapting to the repeated bursts of glutamate caused by high frequency head impact, and dampens its normal response to glutamate, perhaps as a way to protect the neurons," explains Sloley. She found that there was a shift in the way that neurons detected and responded to glutamate release, which reduced the neurons ability to learn new information.

With a single head hit or infrequent hits, the synapses do not go through this readjustment, Burns says. But after only a week of frequent mild hits, glutamate detection remained blunted for at least a month after the impacts ended. The affected mice showed deficits in learning and memory, compared to a placebo group of animals.

The authors confirmed that the changes in cognition were due to glutamate by giving a group of mice a drug to block glutamate transmission before they experienced the series of head knocks. This drug is FDA-approved for the treatment of Alzheimer's disease. Despite being exposed to the hits, these mice did not develop adaptations in their synapses or neurotransmission, and did not develop cognitive problems.

"This tells us that the cognitive issues we see in our head impact mice are occurring due to a change in the way the brain is working, and not because we have irreparable brain damage or CTE," Main says. "It would be very unlikely that we would use a drug like this in young players as a neuroprotectant before they play sports, because not all players will develop cognitive disorders," he says. "More much likely is that we can use our findings to develop treatments that target the synapses and reverse this condition. That work is already underway"

Burns believes that CTE and this newly discovered mechanism is different. "I believe that CTE is a real concern for athletes exposed to head impact, but I also believe that our newly discovered communication issue is independent of CTE. While it is concerning that head impacts can change the way the brain works, this study reveals that learning and memory deficits after repeated head impacts do not automatically mean a future with an untreatable neurodegenerative disease."

Source:

Journal reference:

Sloley, S.S., et al. (2021) High-frequency head impact causes chronic synaptic adaptation and long-term cognitive impairment in mice. Nature Communications. doi.org/10.1038/s41467-021-22744-6.

More here:
Cognitive problems caused by repetitive and mild blows to the head could be treated, study suggests - News-Medical.Net

Soldier-Inspired Innovation Incubator team advances to finals for $500000 xTechBOLT prize – Vanderbilt University News

By Jenna Somers

During battle, many soldiers who become wounded find themselves at the mercy of another soldiers medical training, hoping beyond hope that the soldier administering aid will remember their training well enough to save the wounded soldiers life. Under such duress, recalling the details of medical training could be difficult, and the failure of memory lethal.

But what if there were a way to augment brain function for improved medical learning retention? A transdisciplinary team from Vanderbilt, Soterix Medical and the U.S. Army is collaborating to answer that question. Recently, the team advanced to the finals of the U.S. Army Medical Research and Development Commands xTechBrain Operant Learning TechnologyxTechBOLTprize competition, where they will compete in November with four other teams for the $500,000 first-place prize.

Promoting high-risk, high-reward research in memory retention is the goal of the competition, and the Vanderbilt teams expertise in educational neuroscience, industry innovation and military needs may prove to be the winning combination. Their interdisciplinary collaboration stems from the 2020 Trans-institutional Programs (TIPs) initiative award, Soldier-Inspired Innovation Incubator for Discovering Research-Based Solutions (VRA), which supports research at the School of Engineering, College of Arts and Science, Peabody College, School of MedicineClinical, and Owen Graduate School of Management. As the first university to sign an Educational Partnership Agreement with the Army Futures Command, Vanderbilt is a leader in soldier-inspired innovation, and the work of the xTechBOLT team is the latest example of that leadership.

Led by Katherine Aboud, postdoctoral fellow and National Institutes of Health Outstanding Scholar of Neuroscience, and her mentor, Laurie Cutting, Patricia and Rodes Hart Professor at Peabody College and a member of the Vanderbilt Brain Institute, the team is using high-resolution brain data imaging based on research from Cuttings Education and Brain Science Research Lab to develop an individualized, high-definition non-invasive brain stimulation (HD-NIBS) protocol for accelerated medical learning in the classroom. They will then track how medical learning translates to performance on medical simulation tasks. Specifically, they aim to improve performance on the Expert Field Medical Badge Test, the most failed medical test in the Army.

Over the past two decades, my lab has been using multiple neuroimaging modalities, including diffusion tenser imaging, functional magnetic resonance imaging, and volumetric magnetic resonance imaging, in combination with traditional educational approaches to pioneer neural characterization of learning and learning disorders, particularly in the context of language and individual differences in learning, Cutting said. Of particular interest to the [xTechBOLT competition] proposal is the labs groundbreaking work on the role of executive functions and emotional salience on text-based learning, and the neural predictors of these learning outcomes and processes.

The xTechBOLT competition challenges teams to produce a technology that will promote optimal retention and access to memories. The teams software, BRILLIANCE (for Brain tailoRed stImulation protocoL for acceLerated medIcal performance), will allow any non-scientist to facilitate medical learning retention with the click of a button. The software will interpret high-resolution brain data and send targeting information to Soterix Medicals HD-NIBS technology called High-Definition transcranial Alternating Current Stimulation (HD-tACS).Placed on a persons scalp, electrodes promote communication between multiple areas of the brain. In the present study, electrodes will target brain areas that are responsible for higher order learning. Ultimately, the team plans to commercialize BRILLIANCE as a non-invasive, individualized brain stimulation software for accelerated medical performance.

Abouds pioneering research catalyzed the collaboration between Vanderbilt and Soterix Medical. A couple of years ago, Aboud read about the application of Soterix Medicals technology to remove age-related differences in memory between typical older and younger adults. Wanting to collaborate with Soterix Medical on learning retention, she opened up a line of communication with Abishek Datta, chief technology officer, co-founder and scientist at Soterix Medical. Like Aboud, he recognized that a collaboration between Vanderbilt and Soterix Medical could potentially enhance learning retention not just for soldiers but for people of all backgrounds.

Importantly, our HD-tACS technology is painless and allows unobtrusive pairing with other tasksfeatures that will undoubtedly help in transitioning this technology to an operational setting in the future, Datta said. Our research and development team will work closely with Vanderbilt University and the U.S. Army teams and leverage our decade-long experience in optimized brain stimulation solutions to achieve our goal of accelerating learning.

Following the proof-of-concept phase, the team plans to test BRILLIANCE on 120 soldiers from the 101st Airborne Division at Fort Campbell, Kentucky, who volunteered to participate in the study as members of Vanderbilts Soldier-Inspired Innovation Incubator. Directed by Doug Adams, Daniel F. Flowers Professor of Civil and Environmental Engineering, the Soldier-Inspired Innovation Incubator includes soldiers in design processes to ensure that Vanderbilt research and innovation supports their success in training and on the battlefield.

The software being developed by Katherine Aboud, Laurie Cutting, and their team is combining soldiers insights with Vanderbilts trans-institutional capabilities in the neuroscience of learning and industrys capabilities in brain stimulation to develop a state-of-the-art approach for supporting soldier learning and retention, Adams said. This is exactly the kind of high-impact work that the Soldier-Inspired Incubator TIPs is enabling by acquiring instrumentation that our interdisciplinary teams of researchers can use to explore solution concepts with soldiers to address some of the most challenging problems they face.

Vanderbilt also works with Army personnel on campus, such as Lt. Gen. Gary Cheek, director of the Bass Military Scholars Program, and Lt. Col. and Associate Professor of Military Science and Arts and Science Brandon Hulette, who regularly provide guidance to the Soldier-Inspired Innovation Incubator, including supporting the xTechBOLT prize competition proposal. Additionally, Vanderbilt consultant and former Command Innovation Officer of the Army Futures Command Jay Harrison shared critical insights with the team into the structure of competitions like xTechBOLT and helped shape the final proposal.

I am very excited about our teams cutting-edge work. This mechanism of the xTechBOLT competition allows us to consider a level of scientific and technological innovation that you often cant examine through other mechanisms, Aboud said. Beyond the competition, we could really do a lot of good. If were able to enhance medical learning in a meaningful way, the number of applications of this technology in other educational settings would be incredible. Ultimately, we really want to improve peoples lives by helping our brains learn more effectively.

Contact: Brenda Ellis, 615 343-6314brenda.ellis@vanderbilt.edu

Posted on Friday, May 7, 2021 in 101st Airborne Division, 2021 xTechBOLT competition, BRILLIANCE, Doug Adams, neuroscience, TIPs,Civil and Environmental Engineering, Home Features, News, News Sidebar, Research

Originally posted here:
Soldier-Inspired Innovation Incubator team advances to finals for $500000 xTechBOLT prize - Vanderbilt University News

Biogen and Capsigen Announce Collaboration to Discover and Develop Novel AAV Capsids for Targeted CNS and Neuromuscular Disorders – BioSpace

CAMBRIDGE, Mass. and VANCOUVER, Wash., May 10, 2021 (GLOBE NEWSWIRE) -- Biogen Inc.(Nasdaq: BIIB) and Capsigen Inc. announced today that they have entered into a strategic research collaboration to engineer novel adeno-associated virus (AAV) capsids that have the potential to deliver transformative gene therapies that address the underlying genetic causes of various CNS and neuromuscular disorders.

As a part of the collaboration, Capsigens proprietary TRADE platform and associated technologies will be utilized with the aim to create and identify novel AAV capsids tailored to meet disease-specific transduction profiles. Capsids are the protein coat that protects and facilitates delivery of the virus genetic payload into host cells. The collaboration will leverage Capsigens capsid engineering expertise and Biogens discovery, development, manufacturing and commercialization capabilities with the goal to accelerate delivery of gene therapies to patients in need.

Through this collaboration, we aim to solve key technological challenges in the delivery of gene therapies to target tissues. One of our priorities for technology innovation is the discovery of AAV capsids with improved delivery profiles, said Alfred Sandrock, Jr., M.D., Ph.D., Head of Research and Development at Biogen. We are investing for the long-term by building platform capabilities and advanced manufacturing technologies with the goal of accelerating our efforts in gene therapy.

At Capsigen, we believe the next revolution in gene therapy will be driven by engineered AAV capsids designed to meet disease-specific transduction profiles, said John Bial, Chief Executive Officer. Biogen is a leader in neuroscience, and we are excited for the opportunity to work with them to potentially bring new treatments to patients. This collaboration is consistent with our strategy to work with world-class companies to develop the next generation of gene therapies.

Under the terms of the agreement, Capsigen will apply its vector engineering approaches to develop novel capsids designed to meet highly customized, disease-specific transduction profiles. Biogen will receive an exclusive license under Capsigens proprietary technology for an undisclosed number of CNS and neuromuscular disease targets. Capsigen will receive a $15 million upfront payment and is eligible to receive up to $42 million in potential research milestones and up to an additional $1.25 billion in potential development and commercial payments should the collaboration programs achieve certain developmental milestones and sales thresholds. Capsigen is also eligible to receive royalties on future net sales of products that incorporate capsids resulting from the collaboration.

About Biogen At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the worlds first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimers disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, neuropsychiatry, immunology, acute neurology and neuropathic pain.

We routinely post information that may be important to investors on our website at http://www.biogen.com. Follow us on social media Twitter, LinkedIn, Facebook, YouTube.

About CapsigenAt Capsigen, were developing the next generation of AAV vectors to fuel the gene therapy needs of the future. Our end-to-end platform employs customized, highly diverse libraries using the most clinically relevant models and routes of administration. Our proprietary TRADE technology eliminates background and employs novel selection strategies to identify only those vectors which are fully functional and meet the disease-specific transduction criteria of interest. The final results are fit-for-purpose vectors designed to deliver the highest level of clinical utility in a rapid and high-throughput manner.

Biogen Safe HarborThis news release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, relating to the potential benefits and results that may be achieved through Biogens collaboration with Capsigen; the potential benefits of Capsigens TRADE platform; the potential of Biogens commercial business and pipeline programs; Biogens strategy and plans; the potential treatment of neurological and neurodegenerative diseases; and risks and uncertainties associated with drug development and commercialization. These forward-looking statements may be accompanied by words such as aim, anticipate, believe, could, estimate, expect, forecast, intend, may, plan, potential, possible, will, would and other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinical trials may not be indicative of full results or results from later stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements or the scientific data presented.

These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements, including without limitation, uncertainty as to whether the anticipated benefits of the collaboration can be achieved; risks of unexpected costs or delays or other unexpected hurdles; uncertainty of success in the development of potential gene therapies, which may be impacted by, among other things, unexpected concerns that may arise from additional data or analysis, the occurrence of adverse safety events, failure to obtain regulatory approvals in certain jurisdictions, failure to protect and enforce data, intellectual property and other proprietary rights and uncertainties relating to intellectual property claims and challenges; the direct and indirect impacts of the ongoing COVID-19 pandemic on Biogens business, results of operations and financial condition; product liability claims; and third party collaboration risks. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from Biogens expectations in any forward-looking statement. Investors should consider this cautionary statement as well as the risk factors identified in Biogens most recent annual or quarterly report and in other reports Biogen has filed with the U.S. Securities and Exchange Commission. These statements are based on Biogens current beliefs and expectations and speak only as of the date of this news release. Biogen does not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

See the original post:
Biogen and Capsigen Announce Collaboration to Discover and Develop Novel AAV Capsids for Targeted CNS and Neuromuscular Disorders - BioSpace

The Link Between Stroke Risk and Infections COVID Included – Baptist Health South Florida

The impact of COVID-19 on a persons risk of a stroke is being intensely researched. But long before the pandemic, it was well-established that viral and bacterial infections can raise a persons stroke risk, in some cases substantially.

Having even common viral or bacterial infections, such as a UTI (urinary tract infection), can be a co-factor in triggering a stroke. The medical literature commonly refers to influenza-like diseases (ILI) when referencing higher stroke risks, especially among adults who already have underlying health issues such as high blood pressure, diabetes, and heart disease.

Felipe De Los Rios, M.D., medical director of the Stroke Program at Baptist Healths Miami Neuroscience Institute.

This risk of increased stroke with COVID-19 is not unique to COVID-19, explains Felipe De Los Rios, M.D., medical director of the Stroke Program at Baptist Healths Miami Neuroscience Institute. Weve seen this before with a lot of different illnesses. Weve seen it with just urinary infections, other respiratory tract infections, influenza or influenza-like illnesses.

Pre-pandemic studies have indicated that even some adults younger than 45 can have a 9-fold higher stroke risk with influenza-like illnesses. Dr. De Los Rios cautions that its difficult to pinpoint a cause for stroke in younger people with few if any comorbidities, or underlying health issues.

It seems likely that there is a stronger association between COVID as it is with influenza-like illnesses but its difficult to say because you have to correct for lots of other factors, says Dr. De Los Rios.

Infection and Other Risk Factors

Stroke can be caused either by a clot obstructing the flow of blood to the brain (called an ischemic stroke the most common) or by a blood vessel rupturing and preventing blood flow to the brain (called a hemorrhagic stroke). Stroke is the No. 5 cause of death and a leading cause of disability in the United States. When a stroke occurs, part of the brain cannot get the blood (and oxygen) it needs, so brain cells die. (May is Stroke Awareness Month).

The top risk factors for stroke are fairly well known: high blood pressure, cigarette smoking, diabetes, high blood cholesterol levels, a diet high in fat (particularly saturated) and salt, and obesity. However, a lesser understood risk factor is infection, which studies have identified as both a potential chronic risk factor and an acute trigger for stroke.

Research presented at the American Stroke Associations International Stroke Conference in 2019 indicated that having a flu-like illness increased the odds of having a stroke by nearly 40 percent over the next 15 days. Several studies have reached similar conclusions long before the COVID pandemic. A separate study in 2019 of over 190,000 stroke patients found that the risk of suffering a stroke was higher in the weeks following any infection that required a trip to an ER or hospitalization. Urinary tract infections (UTIs) showed the strongest link to higher stroke risk.

Infection Pushes Your Body Off Balance

Why do infections increase a persons risk for a stroke? There are many proposed cause-and-effect mechanisms behind the infection-stroke connection, but theres much uncertainty. Researchers suspect a primary mechanism could be excessive inflammation caused by the infection.

Some studies have found that patients with COVID-19 can develop abnormal blood clotting, mostly a result of excessive inflammation. In response to infections, sometimes the body produces an overactive immune response which can lead to increased inflammation. The coronavirus is known to primarily attack the lungs, but it can also affect many other organs, including the blood. This can lead to clot formation.

Dr. De Los Rios says that understanding the impact of an infection on the body comes down to balance. An infection can push your body off balance that is the main point, he says. The more off balance you are, the higher the risk of stroke. Normally, theres this balance in your body between clotting and bleeding so that we dont experience either of them. But if your body is fighting this infection, which is new and may be severe, then your body reacts to it. And in that process of reaction, there can be collateral damage. And part of that collateral damage is a tendency to form clots.

Tags: COVID-19, Miami Neuroscience Institute, National Stroke Awareness Month, stroke

Go here to read the rest:
The Link Between Stroke Risk and Infections COVID Included - Baptist Health South Florida